The ligand binding assay and its role in understanding adrenergic receptor function
Homcy, C.J.
Journal of Thoracic and Cardiovascular Surgery 86(2): 193-194
1983
ISSN/ISBN: 0022-5223 PMID: 6876856 Document Number: 200039
Document emailed within 1 workday
Related Documents
Wang, C.D.; Buck, M.A.; Fraser, C.M. 1991: Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists Molecular Pharmacology 40(2): 168-179Rudorff, K.H.; Herrmann, J.; Kröll, H.J.; Krüskemper, H.L. 1976: Measurement of thyroxine binding globulin by competitive ligand binding assay (CLBA) Journal of Clinical Chemistry and Clinical Biochemistry 14(1): 31-36
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Vaidyanathan, J.; Chinnaswamy, K.; Vaidyanathan, T.K. 2003: Biomimetic recognition and immunochemical assay of ligand binding to collagen Journal of Adhesive Dentistry 5(1): 7-17
Blake, D.A.; Skarstedt, M.T.; Shultz, J.L.; Wilson, D.P. 1984: Zymogen activation: a new system for homogeneous ligand-binding assay Clinical Chemistry 30(9): 1452-1456
Vollmer, G.; Helmchen, B.; Knuppen, R. 1989: Simultaneous quantification of oestrogen and progesterone receptors by a ligand binding assay in frozen sections Journal of Clinical Chemistry and Clinical Biochemistry 27(12): 953-959
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Neubig, R.R.; Gantzos, R.D.; Brasier, R.S. 1985: Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry Molecular Pharmacology 28(5): 475-486
Li, G.-c.; Zhang, B.-l.; Xia, J.-y.; Fang, Z.-J. 2015: Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands Die Pharmazie 70(8): 511-514
Leysen, J.E.; Gommeren, W. 1982: In vitro binding properties of 3H-sufentanil, a superior ligand for the mu-opiate receptor Archives Internationales de Pharmacodynamie et de Therapie 260(2): 287-289
Blanchard, S.G.; Lee, P.H.; Pugh, W.W.; Hong, J.S.; Chang, K.J. 1987: Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17 Molecular Pharmacology 31(4): 326-333
Schneider, R.J.; Atkinson, J.P.; Krause, V.; Kulczycki, A. 1981: Characterization of ligand-binding activity of isolated murine Fc gamma receptor Journal of Immunology 126(2): 735-740
Force, W.R.; Walter, B.N.; Hession, C.; Tizard, R.; Kozak, C.A.; Browning, J.L.; Ware, C.F. 1995: Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression Journal of Immunology 155(11): 5280-5288
Powell, M.S.; Barnes, N.C.; Bradford, T.M.; Musgrave, I.F.; Wines, B.D.; Cambier, J.C.; Hogarth, P.Mark. 2006: Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding Journal of Immunology 176(12): 7489-7494
Primus, R.J.; Thurkauf, A.; Xu, J.; Yevich, E.; McInerney, S.; Shaw, K.; Tallman, J.F.; Gallagher, D.W. 1997: II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1 Journal of Pharmacology and Experimental Therapeutics 282(2): 1020-1027
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Nakashima, I.; Pu, M.Y.; Nishizaki, A.; Rosila, I.; Ma, L.; Katano, Y.; Ohkusu, K.; Rahman, S.M.; Isobe, K.; Hamaguchi, M. 1994: Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals Journal of Immunology 152(3): 1064-1071
Miklavc, A.; Kocjan, D.; Hadzi, D.; Mavri, J.; Koller, J. 1989: Binding of agonists and antagonists to beta-adrenergic receptor Progress in Clinical and Biological Research 291: 275-280
Quik, M.; Collier, B.; Audhya, T.; Goldstein, G. 1990: Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction Journal of Pharmacology and Experimental Therapeutics 254(3): 1113-1119
Melamed, J.; Arnaout, M.A.; Colten, H.R. 1982: Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release Journal of Immunology 128(5): 2313-2318